Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.93 USD | +1.02% | +2.82% | +53.32% |
05-09 | Earnings Flash (ADMA) ADMA BIOLOGICS Posts Q1 Revenue $81.9M, vs. Street Est of $77.3M | MT |
04-02 | ADMA Biologics, Inc. Announces Promotion of Kaitlin Kestenberg as Chief Operating Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+53.32% | 1.59B | |
-2.99% | 88.91B | |
+2.76% | 41.25B | |
-13.92% | 31.99B | |
+50.51% | 24.73B | |
-15.25% | 15.54B | |
-39.93% | 12.07B | |
-9.08% | 12.05B | |
-14.80% | 12.02B | |
+6.22% | 8.84B |
- Stock Market
- Equities
- ADMA Stock
- News ADMA Biologics, Inc.
- HC Wainwright Adjusts Price Target on ADMA Biologics to $6 From $5, Maintains Buy Rating